We have collected information about Pancreatic Cancer Drug Delivery for you. Follow the links to find out details on Pancreatic Cancer Drug Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815202/
The most commonly used carriers for drug delivery in pancreatic cancer treatment include liposomes, nanoparticles, and carbon nanotubes. Those carriers can protect the drugs from degradation and will effectively deliver them to the target organs.
https://www.sciencedirect.com/science/article/pii/S0304419X09000729
The most commonly used carriers for drug delivery in pancreatic cancer treatment include liposomes, nanoparticles, and carbon nanotubes . These carriers can protect the drugs from degradation and will effectively deliver them to the target organs.Author: Xianjun Yu, Yuqing Zhang, Changyi Chen, Qizhi Yao, Min Li
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844509/
Mar 03, 2010 · Drug Delivery in Pancreatic Cancer . Chemotherapeutic agents are often administered systemically; thus, drug delivery to a tumor involves several processes including transport within a vessel, transport across the vessel wall into surrounding tissues, and transport through interstitial space within a tumor . Each process is affected by both the physicochemical properties of the drug…Author: Jing Li, M. Guillaume Wientjes, Jessie L.-S. Au
https://www.pancan.org/research/strategic-research-program/news/new-strategy-to-improve-drug-delivery-to-pancreatic-tumors/
Since chemotherapeutics and other cancer drugs are administered intravenously, the poor blood supply to pancreatic tumors also impedes drug delivery. A mouse model of pancreatic cancer that Dr. Hingorani helped develop mimics this feature of human pancreatic cancer.
https://www.statnews.com/2018/12/14/panther-therapeutics-patch-pancreatic-cancer/
Dec 14, 2018 · Startup Spotlight: PanTher’s drug-delivery patch aims to knock down the ‘wall’ of pancreatic cancer. Wherever there has been a stage for biotech entrepreneurs this fall, Laura Indolfi …
https://www.genengnews.com/news/disrupting-pancreatic-cancer-ph-may-hold-therapeutic-potential/
Apr 08, 2020 · “Pancreatic cancer is predicted to soon become the second-leading cause of cancer-related deaths in the U.S.,” noted Cosimo Commisso, PhD, assistant professor at Sanford Burnham Prebys Cancer ...
http://pancreatic.org/chemotherapy-nanoparticles-offer-breakthrough-in-pancreatic-cancer-drug-delivery/
Apr 18, 2017 · Pancreatic ductal adenocarcinoma is generally a fatal disease, with a five-year survival rate of less than 6 percent. The introduction of nanocarriers as delivery vehicles for common chemotherapy agents such as the drug irinotecan, has led …
https://www.nature.com/articles/s41392-017-0004-3
Mar 16, 2018 · Alginate-PAMAM dendrimer-based hybrid nanogels have been developed for drug delivery to cancer cells, and they showed pH-dependent release behavior in a sustained way 131. Nanocarriers have been ...Author: Sudipta Senapati, Arun Kumar Mahanta, Sunil Kumar, Pralay Maiti
https://www.sciencedirect.com/science/article/pii/S0142961216302861
Nanoparticle-encapsulated drugs (nanocarrier-drug delivery systems) comprise the therapeutic entities, such as chemotherapeutic drugs and therapeutic siRNA , , , , and the nanocarriers formed by biocompatible materials, such as polymers and liposomes , , , , .Author: Xiao Zhao, Xiao Zhao, Keni Yang, Ruifang Zhao, Tianjiao Ji, Xiuchao Wang, Xiao Yang, Yinlong Zhang, ...
Searching for Pancreatic Cancer Drug Delivery?
You can just click the links above. The data is collected for you.
